Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint (Q30620954)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint
scientific article

    Statements

    Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint (English)
    1 January 2001

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit